Substance / Medication

Bacampicillin

Overview

Active Ingredient
bacampicillin
RxNorm CUI
18687

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

14
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Urethral stricture: etiology, investigation and treatments.
Tritschler Stefan, Roosen Alexander, Füllhase Claudius et al. · Dtsch Arztebl Int · 2013
PMID: 23596502Meta-AnalysisFull text (PMC)
Strategies for partner notification for sexually transmitted infections, including HIV.
Ferreira Adel, Young Taryn, Mathews Catherine et al. · Cochrane Database Syst Rev · 2013
PMID: 24092529Meta-AnalysisFull text (PMC)
Genital ulcerative disease and sexually transmitted urethritis and circumcision: a meta-analysis.
Van Howe Robert S · Int J STD AIDS · 2007
PMID: 18073009Meta-Analysis
Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.
Lau Chuen-Yen, Qureshi Azhar K · Sex Transm Dis · 2002
PMID: 12218839Meta-Analysis
Strategy to control catheter encrustation with citrated drinks: a randomized crossover study.
Khan Azhar, Housami Fadi, Melotti Roberto et al. · J Urol · 2010
PMID: 20171661RCT
[Oesophageal ulcer associated with the use of bacampicillin].
Béchade Dominique, Desramé Jérôme, Raynaud Jean-Jacques et al. · Presse Med · 2005
PMID: 15798551Case Report
Bacampicillin uptake is shared with thiamine in Caco-2 cells.
Oda Masako, Fujimoto Kaori, Kobayashi Michiya et al. · Biol Pharm Bull · 2007
PMID: 17603179Other
Characterization of primary recall in vitro lymphocyte responses to bacampicillin in allergic subjects.
Cederbrant K, Marcusson-Stâhl M, Hultman P · Clin Exp Allergy · 2000
PMID: 10998023Other
Pharmacokinetics and oral bioavailability of ampicillin and its prodrug bacampicillin in chickens and turkeys.
Guzelaydin Kerem, Gunes Yigit, Anlas Ceren et al. · J Vet Sci · 2025
PMID: 40183908PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bacampicillin (substance)
SNOMED CT
372865005
UMLS CUI
C0052865
RxNorm CUI
18687

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

14
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
14
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.